1. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J, 2010, 35(4): 913-922.
[2]
2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J, 2009, 33(5): 1165-1185.
[3]
3. Thakur N, Blank PD, Julian LJ, et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis, 2010, 5: 263-269.
[4]
4. Galimberti D, Schoonenenboom N, Scarpini E, et al. Dutch-Italian Alzheimer Research Group: Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol, 2003, 53(4): 547-548.
8. Bozinovski S, Hutchinson A, Thompson M, et al. Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2008, 177(3): 269-278.
[9]
9. Lima OM, Oliveira-souzaS R, Santos-oda R, et al. Subclinical encephalopathy in chronic obstructive pulmonary disease. Arq Neuropsiquiatr, 2007, 65(4B): 1154-1157.
[10]
10. Incalzira, Gemma A, Marra C, et al. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest, 1997, 112(6): 1506-1513.
12. Yu Y, Liu J, Li S Q, et al. Serum amyloid a differentially activates microglia and astrocytes via the PI3K pathway. Alzheimers Dis, 2014, 38(1): 133-144.
[13]
13. 董哲. 血清淀粉样蛋白 A 加速动脉粥样硬化斑块形成及其致炎作用的机制研究[D]. 山东: 山东大学, 2012.
